Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010-2019

被引:48
|
作者
Morton, Jedidiah I. [1 ,2 ]
Lazzarini, Peter A. [3 ,4 ,5 ]
Shaw, Jonathan E. [1 ,2 ]
Magliano, Dianna J. [1 ,2 ]
机构
[1] Baker Heart & Diabet Inst, Melbourne, Australia
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Australia
[3] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Australia
[4] Queensland Univ Technol, Ctr Hlth Serv Innovat & Ctr Healthcare Transformat, Brisbane, Australia
[5] Prince Charles Hosp, Allied Hlth Res Collaborat, Brisbane, Australia
基金
英国医学研究理事会;
关键词
LOWER-EXTREMITY AMPUTATION; CARDIOVASCULAR-DISEASE; SEVERE HYPOGLYCEMIA; LIFE EXPECTANCY; UNITED-STATES; ADULTS; RATES; US; KETOACIDOSIS; MORTALITY;
D O I
10.2337/dc21-2268
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVETo determine trends in the incidence of major diabetes-related complications in Australia. RESEARCH DESIGN AND METHODSThis study included 70,885 people with type 1 and 1,089,270 people with type 2 diabetes registered on the Australian diabetes registry followed from July 2010 to June 2019. Outcomes (hospitalization for myocardial infarction [MI], stroke, heart failure [HF], lower-extremity amputation [LEA], hypoglycemia, and hyperglycemia) were obtained via linkage to hospital admissions databases. Trends over time in the age-adjusted incidence of hospitalizations were analyzed using joinpoint regression and summarized as annual percent changes (APCs). RESULTSIn type 1 diabetes, the incidence of all complications remained stable, except for stroke, which increased from 2010-2011 to 2018-2019 (financial years; APC: +2.5% [95% CI 0.1, 4.8]), and hyperglycemia, which increased from 2010-2011 to 2016-2017 (APC: +2.7% [1.0, 4.5]). In type 2 diabetes, the incidence of stroke remained stable, while the incidence of MI decreased from 2012-2013 to 2018-2019 (APC: -1.7% [95% CI -2.8, -0.5]), as did the incidence of HF and hypoglycemia from 2010-2011 to 2018-2019 (APCs: -0.8% [-1.5, 0.0] and -5.3% [-6.7, -3.9], respectively); the incidence of LEA and hyperglycemia increased (APCs: +3.1% [1.9, 4.4], and +7.4% [5.9, 9.0]). Most trends were consistent by sex, but differed by age; in type 2 diabetes most improvements were confined to individuals aged >= 60 years. CONCLUSIONSTrends in admissions for diabetes-related complications were largely stable in type 1 diabetes. In type 2 diabetes, hospitalization rates for MI, HF, and hypoglycemia fell over time, while increasing for LEA and hyperglycemia.
引用
收藏
页码:789 / 797
页数:9
相关论文
共 50 条
  • [21] Relationship Between Glycemic Control and Diabetes-Related Hospital Costs in Patients with Type 1 or Type 2 Diabetes Mellitus
    Menzin, Joseph
    Korn, Jonathan R.
    Cohen, Joseph
    Lobo, Francis
    Zhang, Bin
    Friedman, Mark
    Neumann, Peter J.
    JOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (04): : 264 - 275
  • [22] Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank
    Zhang, Xinyu
    Zhao, Shuzhi
    Huang, Yikeng
    Ma, Mingming
    Li, Bo
    Li, Chenxin
    Zhu, Xinyu
    Xu, Xun
    Chen, Haibin
    Zhang, Yili
    Zhou, Chuandi
    Zheng, Zhi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (11):
  • [23] Diabetes-related distress and quality of life among people with type 2 diabetes at primary care level in Brazil
    Neves, Natalia Wilcesky Tosini
    Breder, Jessica Silva Cunha
    Oliveira, Bruna Andrade
    Zanchetta, Flavia Cristina
    Barreto, Joaquim
    Sposito, Andrei C.
    Lima, Maria Helena Melo
    ACTA DIABETOLOGICA, 2024, 61 (04) : 461 - 471
  • [24] Obesity paradox in associations between body mass index and diabetes-related hospitalization and mortality in patients with type 2 diabetes: Retrospective cohort studies
    Lin, Cheng-Chieh
    Li, Chia-Ing
    Liu, Chiu-Shong
    Lin, Wen-Yuan
    Lin, Chih-Hsueh
    Chiang, Jason I.
    Yang, Shing-Yu
    Li, Tsai-Chung
    DIABETES & METABOLISM, 2019, 45 (06) : 564 - 572
  • [25] Epigenetics of type 2 diabetes and diabetes-related outcomes in the Strong Heart Study
    Domingo-Relloso, Arce
    Gribble, Matthew O.
    Riffo-Campos, Angela L.
    Haack, Karin
    Cole, Shelley A.
    Tellez-Plaza, Maria
    Umans, Jason G.
    Fretts, Amanda M.
    Zhang, Ying
    Fallin, M. Daniele
    Navas-Acien, Ana
    Everson, Todd M.
    CLINICAL EPIGENETICS, 2022, 14 (01)
  • [26] Prevalence of Type 1 and Type 2 Diabetes-Related Complications and Their Association With Determinants Identified in Canada's Survey on Living With Chronic Diseases-Diabetes Component
    Yaghoubi, Mohsen
    Mansell, Kerry
    Vatanparast, Hassanali
    Steeves, Megan
    Zeng, Wu
    Farag, Marwa
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (04) : 304 - +
  • [27] Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes The Pittsburgh Epidemiology of Diabetes Complications Study
    Miller, Rachel G.
    Secrest, Aaron M.
    Ellis, Demetrius
    Becker, Dorothy J.
    Orchard, Trevor J.
    DIABETES CARE, 2013, 36 (12) : 3999 - 4006
  • [28] Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
    Kiadaliri, Aliasghar A.
    Gerdtham, Ulf-G
    Eliasson, Bjoern
    Gudbjoernsdottir, Soffia
    Svensson, Ann-Marie
    Carlsson, Katarina Steen
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2014, 11 (05): : 4939 - 4952
  • [29] Diabetes-related shame among people with type 2 diabetes: an internet-based cross-sectional study
    Inagaki, Satoshi
    Matsuda, Tomokazu
    Muramae, Naokazu
    Abe, Kozue
    Kato, Kenji
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (06)
  • [30] Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study
    Hamilton, Emma J.
    Davis, Wendy A.
    Baba, Mendel
    Davis, Timothy M. E.
    DIABETES & VASCULAR DISEASE RESEARCH, 2023, 20 (01)